Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A Response to the Letter to the Editor: "Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC?"
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 17, 2025
Based on the CROWN Findings, Lorlatinib Should Be the Preferred First-Line Treatment for Patients With Advanced ALK-Positive NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 17, 2024
Treatment of non-small cell lung cancer with RET rearrangements.
Journal: Cancer
Published: June 27, 2024
Optimizing Dosing of Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always Better.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 11, 2023
LASERing FLAURAL Arrangements in Asian EGFR Subsets.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 10, 2023
Antibody-Drug Conjugates for Lung Cancer: Payloads and Progress.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 10, 2023
Showing 1-6 of 6
Last Updated: 09/26/2026